WHO ICTRP trial

Study to assess the inhalation profile obtained by acoustic monitoring in COPD…

EUCTR2013-000262-11-IT · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2013-000262-11-IT
Public title Study to assess the inhalation profile obtained by acoustic monitoring in COPD patients using the inhaler NEXThaler®
Scientific title An Open Label Placebo Study To Assess The Inhalation Profile Obtained By Acoustic Monitoring In COPD Patients Using The NEXThaler® Dry Powder Inhaler (DPI) Device.
Primary sponsor Chiesi Farmaceutici S.p.A.
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Countries Italy
Conditions COPD MedDRA version: 16.0 Level: LLT Classification code 10010952 Term: COPD System Organ Class: 100000004855 ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
Interventions Product Name: CHF 1535 NEXThaler® Placebo Pharmaceutical Form: Inhalation powder
Registration date May 16, 2013
Secondary IDs CCD_01535BC1_01
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations